Aspiriant LLC’s iShares Core S&P 500 ETF IVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432M Buy
661,906
+33,997
+5% +$23.2M 12.31% 1
2025
Q4
$430M Buy
627,909
+29,480
+5% +$20M 12.36% 1
2025
Q3
$401M Sell
598,429
-26,291
-4% -$16.9M 12.25% 1
2025
Q2
$388M Buy
624,720
+40,785
+7% +$23.4M 12.33% 1
2025
Q1
$328M Buy
583,935
+48,199
+9% +$28.5M 11.39% 1
2024
Q4
$315M Buy
535,736
+95,605
+22% +$56.6M 11.39% 1
2024
Q3
$254M Buy
440,131
+32,303
+8% +$18M 9.63% 4
2024
Q2
$223M Buy
407,828
+53,889
+15% +$28.3M 9.1% 4
2024
Q1
$186M Buy
353,939
+203,445
+135% +$102M 7.7% 4
2023
Q4
$71.9M Buy
150,494
+15,179
+11% +$6.79M 3.24% 6
2023
Q3
$58.1M Buy
135,315
+17,452
+15% +$7.81M 2.97% 7
2023
Q2
$52.5M Buy
117,863
+11,318
+11% +$4.77M 2.66% 10
2023
Q1
$43.8M Buy
106,545
+2,837
+3% +$1.14M 2.29% 10
2022
Q4
$39.8M Sell
103,708
-503
-0.5% -$194K 2.03% 10
2022
Q3
$37.4M Buy
104,211
+293
+0.3% +$117K 1.83% 11
2022
Q2
$39.4M Buy
103,918
+150
+0.1% +$61.7K 1.9% 12
2022
Q1
$47.1M Sell
103,768
-291
-0.3% -$130K 2.59% 11
2021
Q4
$49.6M Sell
104,059
-5,071
-5% -$2.34M 2.65% 10
2021
Q3
$47M Sell
109,130
-2,881
-3% -$1.28M 2.76% 9
2021
Q2
$48.2M Buy
112,011
+22,407
+25% +$9.39M 2.72% 9
2021
Q1
$35.6M Sell
89,604
-2,085
-2% -$807K 2.28% 13
2020
Q4
$34.4M Buy
91,689
+4,186
+5% +$1.49M 2.35% 13
2020
Q3
$29.4M Sell
87,503
-1,920
-2% -$639K 2.3% 13
2020
Q2
$27.7M Sell
89,423
-6,264
-7% -$1.84M 2.57% 12
2020
Q1
$24.7M Sell
95,687
-14,806
-13% -$4.54M 2.44% 12
2019
Q4
$35.7M Sell
110,493
-1,346
-1% -$417K 3.31% 8
2019
Q3
$33.4M Sell
111,839
-5,583
-5% -$1.66M 2.99% 9
2019
Q2
$34.6M Sell
117,422
-5,661
-5% -$1.64M 2.89% 10
2019
Q1
$35M Buy
123,083
+1,066
+0.9% +$291K 2.86% 11
2018
Q4
$30.7M Sell
122,017
-4,697
-4% -$1.28M 2.33% 13
2018
Q3
$37.1M Sell
126,714
-4,100
-3% -$1.18M 3.17% 9
2018
Q2
$35.7M Sell
130,814
-10,333
-7% -$2.81M 3.06% 8
2018
Q1
$37.5M Buy
141,147
+58,457
+71% +$16.1M 3.27% 7
2017
Q4
$22.2M Sell
82,690
-59,998
-42% -$15.7M 6.53% 3
2017
Q3
$36.1M Sell
142,688
-9,992
-7% -$2.48M 3.03% 8
2017
Q2
$37.2M Sell
152,680
-8,223
-5% -$1.98M 3.23% 8
2017
Q1
$38.2M Sell
160,903
-16,941
-10% -$3.96M 3.25% 5
2016
Q4
$40M Sell
177,844
-27,312
-13% -$6M 3.62% 6
2016
Q3
$44.6M Sell
205,156
-60,786
-23% -$13.2M 4.44% 6
2016
Q2
$56M Sell
265,942
-32,681
-11% -$6.82M 5.29% 6
2016
Q1
$61.7M Sell
298,623
-54,915
-16% -$10.8M 5.89% 6
2015
Q4
$72.4M Sell
353,538
-37,166
-10% -$7.68M 7.96% 5
2015
Q3
$75.3M Sell
390,704
-16,897
-4% -$3.45M 6.26% 5
2015
Q2
$84.5M Sell
407,601
-48,091
-11% -$10.2M 8.24% 6
2015
Q1
$94.7M Sell
455,692
-40,919
-8% -$8.51M 12.28% 2
2014
Q4
$103M Sell
496,611
-92,728
-16% -$18.8M 13.74% 1
2014
Q3
$117M Sell
589,339
-57,136
-9% -$11.4M 16.32% 2
2014
Q2
$127M Buy
646,475
+3,114
+0.5% +$596K 17.55% 2
2014
Q1
$121M Buy
643,361
+16,013
+3% +$2.96M 17.54% 2
2013
Q4
$116M Buy
627,348
+50,218
+9% +$8.94M 18.15% 2
2013
Q3
$97.5M Sell
577,130
-11,457
-2% -$1.93M 17.46% 2
2013
Q2
$94.7M Buy
+588,587
New +$95.3M 14.87% 2

Other funds holding IVV

Aspiriant LLC's IVV Position: Q1 2026 in Review

Aspiriant LLC increased its iShares Core S&P 500 ETF (IVV) stake by 5.4% in Q1 2026, buying an estimated $23.2M and bringing the position to 661,906 shares worth $432M. The position accounts for 12.31% of the portfolio, ranked #1.

Aspiriant LLC first reported a position in IVV in Q2 2013 and has held it in 52 quarters since. 3,975 funds tracked by Wall St. Rank hold IVV as of Q1 2026.

  • Aspiriant LLC held 661,906 shares of iShares Core S&P 500 ETF worth $432M as of Q1 2026.
  • Aspiriant LLC bought 33,997 iShares Core S&P 500 ETF shares in Q1 2026, an estimated $23.2M.
  • iShares Core S&P 500 ETF made up 12.31% of Aspiriant LLC's portfolio in Q1 2026, its #1 holding.
  • Aspiriant LLC first reported a position in iShares Core S&P 500 ETF in Q2 2013 and has held it in 52 quarters since.
  • 3,975 funds tracked by Wall St. Rank held iShares Core S&P 500 ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.